Reaction of methyl N-Boc-N-phenoxycarbonylglycinate with various aldehydes afforded the corresponding cis-4,5-oxazolidinone derivatives, which were effectively converted to (E)-¡,¢-didehydroamino acids by means of a base. Furthermore, N-deprotection of the oxazolidinone derivatives and subsequent coupling reaction with Boc-amino acid furnished the corresponding dipeptides, which were transformed to dipeptide containing ¡,¢-didehydroamino acid with high E selectivity.
Much attention has been focused on naturally occurring peptides containing ¡,¢-didehydroamino acids 1 and their derivatives from the view point of both synthetic interest and the relationship between their structure and bioactivities. 2 Therefore, much work related to the preparation of ¡,¢-didehydroamino acids has been reported in which the products bearing thermodynamically controlled alkene geometry, (Z)-¡,¢-didehydroamino acids were predominantly formed.
3 In previous papers, we have reported that N-t-butoxycarbonyl (Boc)-or N-benzyloxycarbonyl (Z)-¡-tosylglycine ester was reacted with either a variety of nitro alkanes in the presence of base or various aldehydes in the presence of base and tributylphosphine to afford the corresponding ¡,¢-didehydroamino acid derivatives with high Z selectivity in good yields. 4 The latter procedure was successfully applied to the synthesis of optically active 4-hydroxyprolines. 5 On the contrary, there are few reports 6 concerning stereoselective synthesis of (E)-¡,¢-didehydroamino acid since its stereochemistry is not always thermodynamically favored, for example, 1) stereoselective elimination of hydrogen chloride from erythro-¢-chloro-¡-amino acid derived from threo-¢-hydroxy-¡-amino acid derivative, 6a 2) stereospecific dehydration of erythro-¢-hydroxy-¡-amino acid derivative using DAST [(diethylamino)sulfur trifluoride], 6b 3) formation of cyclic cis-sulfamidite starting from erythro-¢-hydroxy-¡-amino acid derivative and thionyl chloride, and subsequent elimination of sulfur dioxide, 6c 4) Suzuki coupling of ¢-bromo-¡,¢-didehydroamino acid derivative with monosubstituted boronic acid, 6d 5) stereospecific dehydration of erythro-¢-hydroxy-¡-amino acid derivative using Martin's sulfurane [diphenylbis (1,1,1,3,3,3-hexafluoro-2-phenyl-2-propyl) sulfurane], 6e 6) stereospecific dehydration of threo-¢-hydroxy-¡-amino acid derivative with EDC [1-ethyl-3-(3-dimethylaminopropyl) carbodiimide], 6f 7) oxidation of 3-S-benzylthioamino acid derivative to the sulfoxide, followed by thermolysis to form ¡,¢-didehydroamino acid. Although enantiomerically pure ¢-hydroxy-¡-amino acid derivative or ¢-bromo-¡,¢-didehydroamino acid derivative is required for preparation of the starting material as mentioned above, 3b,6 we now wish to report a new and effective stereoselective synthesis of (E)-¡,¢-didehydroamino acid derivative 1 via cis-4,5-oxazolidinone derivative 2 starting from methyl N-Boc-N-phenoxycarbonylglycinate 3f and a variety of aldehydes 4 according to retrosynthetic analysis as shown in Scheme 1. The present method is characterized by stereospecific formation of erythro-¢-hydroxy-¡-amino acid derivative in situ through aldol reaction of 3f with a variety of aldehydes 4, simultaneous conversion to cis-4,5-oxazolidinone derivative 2, which is stereoselectively transformed into (E)-¡,¢-didehydroamino acid derivative 1, and the simplicity of experimental procedure for the preparation.
First, we prepared methyl N,N-diprotected glycinates 3a3f by the reaction of methyl N-monoprotected glycinate 5a5f with di-t-butyl dicarbonate (Boc 2 O). Methyl Boc-glycinate (5a) was treated with 2 molar equivalents of Boc 2 O in the presence of 0.3 molar equivalents of 4-(dimethylamino)pyridine (DMAP) in dry acetonitrile to afford the desired methyl N,Nbis(t-butoxycarbonyl)glycinate (3a) 7 in quantitative yield (Entry 1 in Table 1 ). Similarly, methyl N,N-diprotected glycinates 3b3f were also prepared in good yields as shown in Table 1 (Entries 26) .
Next, formation of cis-4,5-oxazolidinone derivatives through the reaction of ester enolates of 3a3f with benzaldehyde (4i) was examined as a preliminary experiment. The results are summarized in Table 2 . Lithiation of 3a with 1.1 molar equivalents of lithium diisopropylamide (LDA) in tetrahydrofuran (THF) at ¹78°C for 1 h followed by the reaction of the lithium ester enolate thus prepared with 1.1 molar equivalents of benzaldehyde (4i) at ¹78°C for 30 min did not afford the desired product 2i, but methyl 2-(t-butoxycarbonylamino)-3-(t-butoxycarbonyloxy)-3-phenylpropanoate (6) in 85% yield (Entry 1 in Table 2 ). Although the substrates 3b and 3c were treated with benzaldehyde (4i) under similar reaction conditions, no product 2i was obtained (Entries 4 and 5 in Table 2 ). A plausible reaction mechanism for formation of 6 and methyl (Z)-or (E)-N-Boc-¡,¢-didehydrophenylalaninate (1i¤ 3b,3h,8 and 1i) may be explained as follows: the lithium ester enolate derived from 3a was reacted with benzaldehyde (4i) to afford the lithium alkoxide of methyl N,N-diBoc-¢-phenylserinate. Subsequently, the lithium alkoxide anion attacked the carbonyl carbon atom of the N-Boc group resulting in formation of 6 through a five-membered cyclic intermediate. Namely, it reveals that N, O migration of the Boc group took place during the reaction as shown in Scheme 2. Accordingly, in Entry 1, quenching the reaction mixture afforded only 6 in 85% yield, while a mixture of 6 and 1i¤ due to elimination of carbon dioxide and lithium tert-butoxide for longer reaction time as shown in Entry 2, and a mixture of 1i and 1i¤ at elevated temperature in Entry 3 (in Table 2 ) were furnished, respectively. Reversibly, in the cases of the substrates 3d3f, the desired product 2i as a single isomer was obtained in 32%, 40%, and 63% yields, respectively (Entries 68 in Table 2 ). Although the difference between the results using 3a3f is now not clear, the result in Entry 8 may be attributed to stabilities of 3f under these reaction conditions and of the leaving phenoxide anion. The structure of product 2i was confirmed by comparison of its 1 H NMR data with those of the known compound reported by Naito et al. 9a and NOE measurement. The chemical shifts and coupling constant (J = 8.90 Hz) between the hydrogens at the C4C5 position of 2i are fully in agreement with those of the reported values (J = 9.0 Hz). 9a,9b Eventually, it was found that the stereochemical relationship between the hydrogens at the C4C5 position is a cis configuration. As compound 3f among 3a3f examined was found to be a useful starting material for construction of the cis-4,5-oxazolidinone system, the reaction of compound 3f with a variety of aldehydes 4a4h and 4j4l was examined. The results are listed in Table 3 . When the lithium ester enolate derived from 3f at ¹40°C for 1 h in THF was reacted with 1.1 molar equivalents of acetaldehyde (4a) at ¹40°C for 4 h, no product was obtained at all (Entry 1 in Table 3 ). After formation of the lithium ester enolate of 3f at ¹78°C 4a was reacted at ¹40 or ¹78°C for 4 h to furnish the desired product 2a in moderate yields (Entries 2 and 3 in Table 3 ). In a similar manner, the products 2b and 2c were obtained in moderate yields by treating the reaction mixture at ¹78 to ¹40°C for 4 h (Entries 4 and 5 in Table 3 ). In the absence of additive, 2e, 2g, and 2h were produced only in 43%, 42%, and 31% yields, respectively (Entries 7, 9, and 10) . In order to improve the yields by activation of the aldehydes 4e, 4g, and 4h Lewis acids such as Ti(O i Pr) 4 and Cl 2 Ti(O i Pr) 2 were used as an additive to produce the corresponding 2e, 2g, and 2h in 66%, 51%, and 45% yields, respectively (Entries 7, 9, and 10 in Table 3 ). In the cases of aromatic aldehydes 4j4l the desired products 2j2l were also obtained in moderate yields (Entries 1113 in Table 3 ). a) Methyl 2-(t-butoxycarbonylamino)-3-(t-butoxycarbonyloxy)-3-phenylpropanoate (6) was obtained in 85% yield. b) 56% of compound 6 and 11% of methyl (Z)-N-Boc-¡,¢-didehydrophenylalaninate (1i¤) were obtained. c) A mixture of 1i¤ and methyl (E)-N-Boc-¡,¢-didehydrophenylalaninate (1i) was obtained in 36% and 25% yields, respectively. d) Recovery of 3b in 38% yield. e) Recovery of 3c in 45% yield along with 37% of 5c. f) Recovery of 3d in 16% yield.
Stereoselective formation of 4,5-cis-oxazolidinone derivative 2 might be explained as follows. The silyl enol ester and the O-alkylated enol ester were first isolated to determine configuration of the lithium ester enolate formed in the solution. Namely, the lithium ester enolate derived from 3a or 3f with LDA at ¹78°C in THF was treated with excess of chlorotrimethylsilane, t-butyldimethylsilyl trifluoromethanesulfonate, t-butyldiphenylsilyl chloride (TBDPS-Cl), or benzyl bromide. 10 Unfortunately all attempts failed. The reaction might proceed via TS 1 with the least steric hindrance among TS 1 to TS 4 to afford the lithium alkoxide of the corresponding erythro-¢-hydroxy-¡-amino acid ester.
11 Subsequently, nucleophilic attack of the alkoxide anion thus formed onto the carbonyl carbon atom of the N-phenoxycarbonyl group might proceed and the subsequent elimination of the lithium phenoxide gives the desired cis-4,5-oxazolidinone derivative 2 as shown in Scheme 3.
As synthetic route to cis-4,5-oxazolidinone derivatives 2a2l starting from 3f and aldehydes 4 was achieved, conversion of diastereomerically pure compounds 2a2l into (E)-¡,¢-dide- a) The lithium ester enolate was prepared at ¹40°C. b) LiHMDS was used as base.
Syntheses of (E)-¡,¢-Didehydroamino Acid Bull. Chem. Soc. Jpn. Vol. 82, No. 3 (2009) hydroamino acid derivatives 1a1l was examined under basic conditions. The results are listed in Table 4 . Various bases such as 1,4-diazabicyclo[2.2.2]octane (DABCO), 1,8-diazabicyclo-[5.4 .0]undec-7-ene (DBU), KO t Bu, KOH, and lithium hexamethyldisilazide (LiHMDS) in THF were used. Eventually, LiHMDS was base of choice among bases tested in THF to afford ¡,¢-didehydroamino acid derivatives 1a1l predominantly accompanied by ¡,¢-didehydroamino acid derivatives 1a¤1l¤. Compound 2a was treated with 3.0 molar equivalents of LiHMDS at ¹40°C for 5 min to afford methyl 2-(t-butoxycarbonylamino)-2-butenoate as a separable mixture of 1a and 1a¤ in 57% and 41% yields, respectively (Entry 1 in Table 4 ). On treatment of 2a with 3.0 molar equivalents of LiHMDS at ¹100°C for 30 min, stereoselectivity of E and Z isomers (1a/1a¤) was improved considerably (Entry 3 in Table 4 ). Moreover, 2a was reacted at ¹78°C for 5 min to afford compound 1a in 85% yield (Entry 4). Predominant formation of 1a from 2a might be due to trans elimination by deprotonation with base at the ¡-position of the ester group. 3h In a similar manner, compounds (E)-1b1l were stereoselectively prepared in moderate to high yields (Entries 516). Stereochemistry of 1b, 1d1g, and 1i1l were assigned by NOE measurement without 1c and 1h, whose stereochemistry were determined by isomerization to the corresponding 1c¤ and 1h¤ using a catalytic amount of I 2 (Entries 6 and 12 in Table 4) . 12 The 1 H NMR spectra of 1a¤, 3b,3c,3i,8a 1b¤, 8a 1c¤, 8a 1d¤, 13 1i¤, 3b,8a8c 1k¤, 14 and 1l¤ 15 were satisfactorily in accordance with the reported data of Z isomer.
Because it was found that compounds 2 could be stereoselectively converted into (E)-¡,¢-didehydroamino acid derivatives 1 the present method was employed for synthesis of (3S,5S)-3-(benzyloxycarbonylamino)-5-(t-butyldiphenylsiloxy)-£-lactone (7), 16 known as a key synthetic intermediate of the antibiotic clavalanine 17 isolated from streptomyces clavuligerus according to Scheme 4. First, compound 8 was prepared as the starting material as shown in Table 5 . After 3f was treated with 1.1 molar equivalents of LDA at ¹78°C for 30 min, the resulting lithium ester enolate was reacted with 1.5 molar equivalents of (R)-O-2,3-isopropylideneglycelaldehyde at ¹78°C for 4 h to afford a separable mixture of two diastereomers, of which 8a was produced as an oil and 8a¤ in crystalline form in 22% and 30% yields, respectively (Entry 1 in Table 5 ). As 15.2% and 11.4% NOE between the hydrogens at C4C5 in irradiation of the proton at C4 in products 8a and 8a¤ were observed, the stereochemistry between the hydrogens at C4C5 of the oxazolidinone ring is assigned to be cis configuration. To improve the total yield various reaction conditions were examined. Accordingly, the ratio of two diastereomers was found to be dependent on reaction conditions (Entries 210 in Table 5 ).
Each of diastereomerically pure compounds 8a and 8a¤ thus obtained was individually exposed to the conditions for preparation of ¡,¢-didehydroamino acid via elimination of carbon dioxide as described for preparation of compound 1. The results are summarized in Table 6 . Thus, treatment of 8a (oily form) with 3.0 molar equivalents of LiHMDS at ¹10°C for 5 min furnished compound 9 in a ratio of 78:22 as a mixture of E and Z isomers 18 in 70% yield (Entry 2 in Table 6 ). Similarly, 8a¤ (crystalline form) was reacted with 3.0 molar equivalents of LiHMDS at ¹30°C for 90 min in THF to afford the desired product 9 in a ratio of 85:15 as a mixture of E and Z isomers in 87% yield (Entry 5 in Table 6 ). Formation of a mixture of (E)-and (Z)-9 might be explained as follows: the carbanion generated by deprotonation with LiHMDS undergoes trans elimination of carbon dioxide with retention of stereochemistry to afford (E)-9, however, (Z)-9 is produced due to formation of the ester enolate. Next, conversion of the mixture of diastereomers 9 into compound 7 was performed according to Scheme 4. Treatment of the mixture of diastereomers 9 (E/Z = 78:22) with 1 M HCl in MeOH at room temperature for 1 day gave the desired £-butenolide derivative 10 19 and methyl (4S)-(Z)-2-(N-Bocamino)-4,5-dihydroxy-2-pentenoate in 61% and 19% yields, respectively. Formation of the latter product was probably attributed to deacetalization of the starting Z isomer 9 since the authentic Z isomer 9 prepared by an alternative way 5 afforded only the deacetalization product in 90% yield under the same reaction conditions. Therefore, E isomer 9 was cyclized to the oxazolidinone derivative 10, whereas Z isomer 9 underwent deacetalization. Next, compound 10 was reacted with 1.2 molar equivalents of TBDPS-Cl in the presence of 3 molar equivalents of imidazole at room temperature for 4 h in dimethylformamide (DMF) to afford O-protected product 11 in 80% yield. Hydrogenation of the resulting compound 11 over 20% Pd(OH) 2 carbon in EtOH under hydrogen atmosphere at room temperature for 10 h took place stereospecifically from the less hindered side due to the bulky TBDPSoxymethyl substituent at position 5 to afford exclusively cis 3,5-disubstituted £-lactone derivative 12 as a single isomer in 89% yield, 5 whereas in the case of longer (overnight) reaction time, a mixture of cis and trans isomers was obtained in 62% and 13% yields, respectively. N-Deprotection of the resulting compound 12 by trifluoroacetic acid (TFA) at 0°C to room temperature for 1 h in dichloromethane and subsequent coupling reaction with 1.1 molar equivalents of N-(benzyloxycarbonyloxy)succinimide (Z-ONSu) in the presence of 3 molar equivalents of triethylamine (TEA) at 0°C to room temperature for 2 h in THF afforded the desired compound 7 in 80% yield.
In a previous paper, 12 we reported that isomerization of dipeptide containing (E)-N-Boc-¡,¢-didehydroamino acid residue to the corresponding Z isomer could be readily performed by means of a catalytic amount of iodine. Indeed, stereochemically pure methyl (E)-2(N-t-butoxycarbonylamino)-2-butenoate (1a) was treated with a catalytic amount of iodine at room temperature for 19 h in THF to furnish the corresponding Z isomer 1a¤ in 90% yield (Entry 1 in Table 7 ). In a similar way, pure E isomers 1b1h were smoothly isomerized to the corresponding Z isomers 1b¤1h¤ in high yields. The 1 H NMR data of the products 1a¤1h¤ produced by isomerization were satisfactorily identical with those of the minor products obtained in Entries 412 in Table 4 . The results are summarized in Table 7 .
We next tried to prepare the amide compounds 13a13k¤ by the reaction of diastereomerically pure cis-4,5-oxazolidinoes 2a, 2d, and 2i with N-Boc amino acid derivatives as shown in Table 8 . Thus, after N-deprotection of 2i with 99% formic acid at room temperature for 40 min, the resulting oxazolidinone derivative was treated with 1.1 molar equivalents of LDA at ¹78°C for 5 min in dry THF followed by reaction with 1.1 molar equivalents of the N-hydroxysuccinimide (HONSu) ester of Boc-alanine at ¹78 to ¹10°C for 3 h to afford the corresponding amide product 13i as a major product and 13i¤ as a minor one in 96% total yields as a separable mixture of M. Kometani et al. B u ll. Chem. Soc. Jpn. Vol. 82, No. 3 (2009) two diastereomers with a ratio of 53:47 as shown in Table 8 (Entry 9). Similarly, compounds 13a13h (Entries 18) and 13j13k¤ (Entries 10 and 11) were prepared in satisfactory yields as a separable mixture of two diastereomers without Entries 1, 5, and 8. We next tried to prepare the dipeptide containing (E)-¡,¢-didehydroamino acid residue as shown in Table 9 . Compound 13b, the major product, thus obtained was treated with 4.0 molar equivalents of LiHMDS at ¹45°C for 50 min in THF to afford the corresponding dipeptide 14b and 14b¤ in a ratio of 84:16 in 88% yield (Entry 2 in Table 9 ). Treatment of 13b¤, the minor product, with LiHMDS under the same reaction conditions also resulted in the formation of 14b and 14b¤ in a ratio of 81:19 in 92% yield (Entry 3 in Table 9 ). The major product 14b was found to be methyl (E)-2-(Boc-alanylamino)-2-butenoate, and 14b¤ to be (Z)-2-(Boc-alanylamino)-2-butenoate compared with the reported data 3i,6f,20 and NOE measurement of 14b. From these results, it was found that treatment of both 13b and 13b¤ bearing cis-4,5-oxazolidinone moiety with base afforded the dipeptide 14b bearing (E)-¡,¢-didehydroamino acid residue predominantly with high stereoselectivity accompanied by Z isomer 14b¤ as in the case described for conversion of 2 to 1. In the same way, compounds 14a and 14c14k containing ¡,¢-didehydroamino acid with high E selectivity were prepared in good yields. The results are listed in Table 9 . Stereochemistry of the major products, 14a, 14c, 14d, and 14f14k was assigned to be E configuration by NOE measurement. Stereochemistry of the major product 14e was determined by isomerization to the minor product 14e¤ by means of I 2 . 12 The minor products, 14a¤, 3h,3i,20 14h¤, 3h and 14i¤ 3b,3c were found to be the dipeptide containing (Z)-¡,¢-didehydroamino acid residue according to the reported 1 H NMR data. As mentioned above, the reaction of compound 3f derived from glycine with a variety of aldehydes 4 afforded various kinds of cis-4,5-oxazolidinone derivatives 2, which were readily transformed to the corresponding ¡,¢-didehydroamino acid derivatives with high E selectivity in good yields under basic conditions. Thus, 3f was found to be a very useful building block for the preparation of (E)-¡,¢-didehydroamino acid. Moreover, (E)-¡,¢-didehydroamino acid derivatives thus prepared were satisfactorily isomerized to the corresponding (Z)-¡,¢-didehydroamino acid derivatives by using iodine. Eventually, the present method will supply a convenient preparation method for both (E)-and (Z)-¡,¢-didehydroamino acid derivatives. In addition, the amide compounds 13 were easily transformed to the corresponding dipeptides 14 containing (E)-¡,¢-didehydroamino acid residue under basic conditions.
Experimental
All of the melting points were determined with a micro melting apparatus (Yanagimoto Seisakusyo) and are uncorrected. The 1 H NMR, IR, and MS spectra were recorded on JEOL JNM-LA 400FT (400 MHz) and LA 300FT (300 MHz) NMR spectrometers, a JASCO FT/IR-230 infrared spectrometer, and a JEOL SX-102A mass spectrometer, respectively. The chemical shifts of the NMR spectra are reported in ¤-relative to TMS as an internal standard. All solvents were distilled and stored over a drying agent. Thinlayer chromatography (TLC) and flash-column chromatography a) A diastereomerically pure isomer of 2a, 2d, and 2i was used. b) Means amino acid abbreviated by three letters. c) Means the ratio of the two diastereomers. -5B), respectively. All crystalline products prepared in the present work were colorless. A General Procedure for Conversion of Oxazolidinones 2a 2l to (E)-¡,¢-Didehydroamino Acid Derivatives 1a1l. To a solution of 2a (81 mg, 0.31 mmol) in dry THF (5 mL) was added LiHMDS (1.55 mmol) in THF at ¹78°C under N 2 . The solution was stirred for 5 min at that temperature and quenched with 1 M AcOH in THF. The solvent was removed in vacuo to give a residue, which was partitioned between ethyl acetate (EtOAc) and water. The EtOAc solution was washed with brine, dried over MgSO 4 , and concentrated under reduced pressure. The residue was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 4/1, v/v) to afford methyl (E)-2-(Boc-amino)-2-butenoate (1a) in 85% (57 mg) and Z isomer, 1a¤ in <13% yields, respectively. (E)-1a: oil; IR (neat): 3457, 3420, 3358, 2979, 2954, 2932, 2394, 2287, 1728, 1651, 1511, 1439, 1365, 1254, 1200, 1163, 1116, 1051, 1013, 937, 888, 850, 829, 800, 771, 3330, 3168, 3007, 2978, 2952, 1722, 1642, 1608, 1586, 1545, 1468, 1455, 1436, 1366, 1329, 1307, 1246, 1220, 1161, 1085, 1048, 1026, 985, 937, 910, 850, 793, 756 The physical and spectral data of compounds 1b1l and 1b¤1l¤ are shown in the following.
Methyl 2-(N-Boc-amino)-2-pentenoate (1b and 1b¤): (E)-1b: oil; IR (neat): 3457, 3419, 3360, 2977, 2935, 2876, 2287, 1707, 1645, 1512, 1457, 1438, 1391, 1366, 1248, 1163, 1050, 1020, 978, 934, 876, 832, 816, 772, 702 IR (neat): 3340, 3120, 2976 IR (neat): 3340, 3120, , 2936 IR (neat): 3340, 3120, , 2877 IR (neat): 3340, 3120, , 1709 IR (neat): 3340, 3120, , 1657 IR (neat): 3340, 3120, , 1496 IR (neat): 3340, 3120, , 1457 IR (neat): 3340, 3120, , 1438 IR (neat): 3340, 3120, , 1391 IR (neat): 3340, 3120, , 1366 IR (neat): 3340, 3120, , 1310 IR (neat): 3340, 3120, , 1247 IR (neat): 3340, 3120, , 1160 IR (neat): 3340, 3120, , 1110 IR (neat): 3340, 3120, , 1049 IR (neat): 3340, 3120, , 1020 3419, 3357, 2969, 2934, 2870, 1729, 1708, 1644, 1513, 1466, 1438, 1366, 1334, 1249, 1161, 1046, 1024, 855 3119, 2964, 2933, 2871, 1710, 1657, 1495, 1438, 1366, 1315, 1258, 1161, 1119, 1049, 1028, 998, 958, 942, 915, 890, 843, 796, 778, 765, 742 3417, 3358, 3086, 3061, 3027, 2979, 2952, 2931, 2860, 2287, 1947, 1727, 1707, 1646, 1604, 1510, 1454, 1438, 1391, 1367, 1243, 1200, 1162, 1094, 1048, 1026, 897, 868, 836, 770, 750, 14 IR (neat): 3339, 3086, 3062, 3027, 2978, 2952, 2931, 1725, 1657, 1604, 1496, 1454, 1437, 1391, 1367, 1269, 1246, 1165, 1085, 1049, 1031, 1003, 912, 882, 845, 798, 775, 749 3898, 3851, 3733, 3708, 3687, 3674, 3647, 3627, 3415, 2954, 2357, 1745, 1695, 1507, 1457, 1441, 1405, 1360, 1322, 1280, 1238, 1161, 1088, 1043, 910, 756 3340, 2978, 2953, 2934, 1714, 1660, 1495, 1455, 1437, 1391, 1382, 1367, 1350, 1275, 1244, 1165, 1097, 1047, 1008, 949, 899, 835, 797, 774, 764, 728, 695 3854, 3735, 3650, 3452, 3188, 2980, 2359, 1727, 1712, 1629, 1519, 1455, 1435, 1398, 1339, 1309, 1257, 1237, 1212, 1148, 1093, 1045, 1028, 986, 922, 849, 765, 741, 3324, 2978, 1734, 1641, 1584, 1545, 1482, 1454, 1435, 1370, 1330, 1308, 1250, 1153, 1086, 1049, 1019, 987, 935, 858, 839, 794, 3389, 3137, 3124, 2983, 2949, 2359, 1736, 1656, 1545, 1496, 1478, 1435, 1390, 1374, 1352, 1308, 1276, 1256, 1225, 1159, 1118, 1050, 1026, 1011, 986, 965, 895, 873, 837, 770 3300, 3134, 2981, 1755, 1738, 1718, 1649, 1550, 1466, 1393, 1368, 1331, 1257, 1234, 1214, 1156, 1063, 1013, 839, 805, Methyl ¡-(N-Boc)-¾-(N¤-Boc-N¤-Z)-¡,¢-didehydrolysinate (1h and 1h¤): (E)-1h: oil; IR (neat): 3365, 3065, 3033, 2979, 2935, 2401, 2291, 1790, 1738, 1588, 1500, 1479, 1456, 1369, 1342, 1286, 1247, 1208, 1154, 1047, 973, 916, 854, 780, 753 Methyl 2-(N-Boc-amino)-3-phenylpropenoate (1i and 1i¤): (E)-1i: oil; IR (neat): 3333, 2979, 1715, 1636, 1514, 1490, 1437, 1368, 1244, 1157, 1057, 1026, 984, 919, 857, 833, 754, 3327, 2990, 2946, 1721, 1700, 1644, 1488, 1445, 1369, 1287, 1242, 1206, 1163, 1143, 1079, 1063, 990, 841, 761, 690 Methyl 3-(p-Bromophenyl)-2-(N-Boc-amino)propenoate (1j and 1j¤): (E)-1j: oil; IR (neat): 3333, 2979, 1725, 1715, 1636, 1514, 1490, 1437, 1368, 1244, 1157, 1057, 1026, 984, 919, 857, 833, 754, 698 ; 10.02%). When the NH proton of the carbamate was irradiated, 3.5% and 1% NOE were observed for the olefinic proton and both ortho protons of the aromatic ring, respectively. (Z)-1j¤: mp 121.0122.0°C (EtOAchexane). IR (KBr): 3327, 2990, 2946, 1721, 1700, 1644, 1488, 1445, 1369, 1287, 1242, 1206, 1163, 1143, 1063, 990, 841, 761, 690 Methyl 2-(N-Boc-amino)-3-(p-tolyl)propenoate (1k and 1k¤): (E)-1k: oil; IR (neat): 3355, 2979, 1725, 1708, 1637, 1607, 1507, 1485, 1438, 1368, 1248, 1159, 1050, 1023, 984, 845, 815, 775 2971, 1708, 1631, 1605, 1488, 1444, 1369, 1342, 1272, 1172, 1136, 1049, 1024, 987, 921, 820, 795, A General Procedure for the Preparation of cis-4,5-Oxazolidin-2-one Derivatives (2a2l). To a solution of 3f (93 mg, 0.30 mmol) in dry THF (1.5 mL) was added 1.1 molar equivalents of LDA at ¹78°C under N 2 . After the solution was stirred at that temperature for 1 h, a solution of benzaldehyde (4i) (35 mg, 0.33 mmol) in THF (1.5 mL) was added dropwise and the solution was kept at ¹78°C for 1 h. The reaction was then quenched with 1 M AcOH in MeOH and the solvent was concentrated under reduced pressure. The residue was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc and the combined extracts were washed with brine, dried over MgSO 4 , and evaporated in vacuo. The residual oil was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 5/1, v/v) to give 3-Boc-4-(methoxycarbonyl)-5-phenyl-cis-4,5-oxazolidin-2-one (2i) in 63% yield (203 mg). Mp 129.0130.0°C (EtOAchexane) (Lit, mp 114 115°C); 9a IR (KBr): 2976 , 1803 , 1750 , 1723 , 1457 , 1441 , 1388 , 1365 , 1312 , 1260 , 1218 , 1189 , 1167 , 1088 , 1050 , 1006 , 5.96 ; N, 4.36%. When the proton at C-4 was irradiated, 12.0% and 2.4% NOE were observed for the proton at C-5 and both ortho protons of the aromatic ring. When the proton at C-5 was irradiated, 15.1% and 11.0% NOE were observed for the proton at C-4 and both ortho protons of the aromatic ring.
The physical and spectral data of compounds 2a2h and 2j2l are shown in the following.
3-Boc-4-methoxycarbonyl-5-methyl-cis-4,5-oxazolidin-2-one (2a): Mp 78.579.5°C (EtOAchexane); IR (KBr): 3007, 2977, 2954, 2939, 2884, 1826, 1759, 1724, 1701, 1587, 1463, 1442, 1396, 1371, 1327, 1299, 1281, 1260, 1220, 1185, 1160, 1120, 1074, 1025 3007, 2977, 2954, 2939, 2884, 1826, 1759, 1724, 1701, 1463, 1442, 1396, 1371, 1327, 1299, 1281, 1260, 1220, 1185, 1160, 1120, 1074 2982, 1824, 1787, 1747, 1371, 1361, 1339, 1331, 1248, 1213, 1188, 1161, 1125, 1096, 1050, 1026, 988 
3-Boc-4-methoxycarbonyl-5-[(N¤-Z)-3¤-indolyl]-cis-4,5-oxazolidin-2-one (2e):
To a solution of 3f (93 mg, 0.30 mmol) in dry THF (5 mL) was added 1.1 molar equivalents of LDA (0. 33 mmol) at ¹78°C under N 2 . After keeping at ¹78°C for 1 h, a solution of 4e (84 mg, 0.30 mmol) in dry THF (2 mL) was added followed by the addition of Ti(O i Pr) 4 (94 mg, 0.33 mmol). The solution was stirred at ¹78°C for 4 h and quenched with 1 M AcOH in THF. After addition of a small amount of water, the mixture was passed through celite. The THF was removed under reduced pressure to give a residue, which was partitioned between EtOAc and water. The EtOAc solution was washed with brine, dried, and evaporated in vacuo to afford a residue, which was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 3/1, v/v). 98 mg of 2e was obtained. Mp 173.0173.5°C (EtOAchexane); IR (KBr): 2979, 1804, 1742, 1609, 1573, 1457, 1407, 1370, 1357, 1315, 1258, 1243, 1220, 1172, 1131, 1102, 1055, 996, 756 When the proton at C-4 was irradiated, 17.5%, 4.3%, and 3.3% NOE were observed for the proton at C-5, 2-position of the indole ring and both the t-butyl protons of the Boc group.
3-Boc-4-methoxycarbonyl-5-[(N¤-Boc)-3¤-indolyl]-cis-4,5-oxazolidin-2-one (2f): Mp 152.0153.0°C (EtOAc); IR (KBr): 2981, 2367, 1800, 1742, 1655, 1596, 1559, 1542, 1508, 1458, 1356, 1318, 1258, 1224, 1154, 1131, 1101, 1051, 992, 844, 788, 770, 18%. When the ¡-proton was irradiated, 13.3% NOE was observed for the ¢-proton.
3-Boc-4-methoxycarbonyl-5-(p-methoxyphenyl)-cis-4,5-oxazolidin-2-one (2l):
Mp 140.0141.00°C (EtOAchexane); IR (KBr): 2979, 1802, 1747, 1721, 1614, 1518, 1447, 1367, 1314, 1251, 1225, 1177, 1161, 1090, 1052, 1034, 1002, 846 7 : C, 58.11; H, 6.02; N, 3.99%. When the ¡-proton of the ester group was irradiated, 12.4% NOE was observed for the ¢-proton.
A General Procedure for the Preparation of N,N-Diprotected Glycine Methyl Esters (3a3f). A solution of methyl Bocglycinate (482 mg, 2.55 mmol), Boc 2 O (1.113 g, 5.10 mmol), and DMAP (93 mg, 0.761 mmol) in dry acetonitrile (CH 3 CN) (5 mL) was stirred at 55°C for 22 h. The solvent was then removed in vacuo to give a residue, which was partitioned between EtOAc and a saturated solution of NH 4 Cl. The aqueous solution was extracted with EtOAc. The combined extracts were washed with brine and dried over MgSO 4 , and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (eluent; hexane/EtOAc = 10/1, v/v) to afford methyl N,N-diBoc-glycinate (3a) in quantitative yield (734 mg). Mp 59.059.5°C (hexane); IR (KBr): 3001, 2978, 1756, 1731, 1694, 1435, 1412, 1383, 1368, 1335, 1231, 1146, 1127, 991, 962, 897, 862, 848, 788 Methyl N-Boc-N-methoxycarbonylglycinate (3d): Oil; IR (neat): 2980, 2958, 1804, 1764, 1703, 1444, 1410, 1369, 1347, 1224, 1155, 1112, 1010, 948, 855, 783 2981, 1803, 1736, 1724, 1700, 1478, 1439, 1418, 1371, 1344, 1223, 1156, 1108, 1025, 959, 926, 893, 856, Methyl N-Boc-N-phenoxycarbonylglycinate (3f): Mp 56.5 57.5°C (hexane); IR (KBr): 2980, 1810, 1753, 1712, 1594, 1494, 1413, 1369, 1347, 1201, 1148, 1099, 1075, 1001, 959, 855, 777 Table 3 was prepared starting from 4-amino-1-butanol.
4-(N-Boc-N-Z-amino)butanal (4h).

4-(N-Boc-N-Z-amino)-butanal (4h) in
To a solution of oxalyl chloride (0.96 mL, 11 mmol) in dry CH 2 Cl 2 (25 mL) added DMSO (2. 13 mL, 30 mmol) 21 at ¹78°C under N 2 . After 15 min, a solution of 17 (3.24 g, 10 mmol) in CH 2 Cl 2 (10 mL) was added and the solution was stirred for 15 min at that temperature. After addition of TEA (10.5 mL, 75 mmol) the mixture was gradually warmed to room temperature and then stirred for 1 h. The solvent was removed in vacuo to give a residue, which was partitioned between EtOAc, Et 2 O, and water. The organic layer was dried over MgSO 4 and evaporated in vacuo to afford a residual oil which was subjected to silica gel column chromatography (eluent, hexane/EtOAc = 2/1, v/v). Compound 4h was obtained in 90% yield (2.90 g). Oil; IR (neat): 2979, 2936, 2823, 2723, 1790, 1724, 1498, 1455, 1369, 1342, 1294, 1264, 1202, 1154, 1119, 1065, 1031, 1003, 854, 779, 752, Methyl 2-(Boc-amino)-3-(t-butoxycarbonyloxy)-3-phenylpropanoate (6). To a solution of 3a (277 mg, 0.79 mmol) in dry THF (4 mL) was added 1.1 molar equivalents of LDA at ¹78°C under N 2 . After the solution was stirred at that temperature for 1 h, a solution of benzaldehyde (4i) (92 mg, 0.87 mmol) in THF (4 mL) was added dropwise at ¹78°C and the solution was kept at ¹78°C for 1 h. After quenching the reaction at that temperature with 0.5 M HCl in MeOH, the solvent was removed in vacuo to give a residue, which was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc. The combined extracts were washed with brine dried over MgSO 4 , and evaporated in vacuo. The residue was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 7/1, v/v) to afford methyl 2-(Bocamino)-3-(t-butoxycarbonyloxy)-3-phenylpropanoate (6) in 85% yield (265 mg). Mp 84.085.0°C (EtOAchexane); IR (KBr): 3404, 2979, 1750, 1702, 1519, 1369, 1287, 1252, 1160, 1090, 1029, 968, 872, 760, (3S,5S)-3-(N-Z-amino)-5-(t-butyldiphenylsiloxy)methyl-£-lactone (7) .
To compound 12 (180 mg, 0.38 mmol) in CH 2 Cl 2 (0.5 mL) was added TFA (0.5 mL) at 0°C under N 2 . The solution was stirred for 1 h at room temperature, and the solvent was removed in vacuo to afford a residue, which was dissolved in THF (3 mL). To the solution was added a solution of TEA (116 mg, 1.15 mmol) in THF (0.5 mL) followed by the addition of N-benzyloxycarbonyloxysuccinimide (Z-ONSu) (144 mg, 0.58 mmol). The solution was allowed to stir for 2 h at room temperature. After evaporation of the solvent the residue was partitioned between EtOAc and water. The EtOAc was washed with brine, dried over MgSO 4 , and evaporated in vacuo to give a residue, which was subjected to preparative TLC (SiO 2 , hexane/ EtOAc = 3/1, v/v). The desired product 7 was obtained in 80% yield (155 mg IR (neat): 3331, 3070, 2931 IR (neat): 3331, 3070, , 2858 IR (neat): 3331, 3070, , 1786 IR (neat): 3331, 3070, , 1713 IR (neat): 3331, 3070, , 1588 IR (neat): 3331, 3070, , 1525 IR (neat): 3331, 3070, , 1471 IR (neat): 3331, 3070, , 1455 IR (neat): 3331, 3070, , 1428 IR (neat): 3331, 3070, , 1362 IR (neat): 3331, 3070, , 1328 IR (neat): 3331, 3070, , 1259 IR (neat): 3331, 3070, , 1198 IR (neat): 3331, 3070, , 1113 IR (neat): 3331, 3070, , 1058 IR (neat): 3331, 3070, , 1027 3-Boc-4-methoxycarbonyl-5-(2,2-dimethyl- [1, 3] dioxolane-4-yl)-cis-4,5-oxazolidin-2-one (8a and 8a¤). To a solution of 3f (309 mg, 1.0 mmol) in dry THF (6 mL) was added 1.1 molar equivalents of LDA (1.1 mmol) at ¹78°C and the solution was stirred for 30 min at that temperature. A solution of (R)-O-2,3-isopropylideneglycelaldehyde (195 mg, 1.5 mmol) in dry THF (5 mL) was added dropwise at ¹78°C followed by the addition of Ti(O i Pr) 4 (427 mg, 1.5 mmol). The resulting solution was allowed to stir for 2 h at ¹78°C and quenched with 1 M AcOH in THF at that temperature. After evaporation of the solvent, the residue was partitioned between EtOAc and water. The EtOAc solution was washed with brine, dried over MgSO 4 , and concentrated under reduced pressure to afford a residue. The crude product was separated by preparative TLC (SiO 2 , hexane/EtOAc = 3/1, v/v) to afford the oxazolidinone derivatives 8a (oily form, 138 mg) in 40% and 8a¤ (crystalline form, <86 mg) in <25% yields, respectively. 8a: oil; IR (neat): 2985, 2937, 1828, 1758, 1730, 1479, 1457, 1438, 1372, 1333, 1255, 1215, 1157, 1068, 846, 2992, 2939, 2899, 1807, 1759, 1723, 1458, 1369, 1337, 1218, 1158, 1103, 1070, 1033, 992, 973, 916, 862, 839, 785, 766 17; H, 6.71 ; N, 4.06%. When the proton at C-4 was irradiated, 11.4% and 1.0% NOE were observed for the proton at C-5 and methyl protons of the ester group, respectively. Methyl (4S)-2-(N-Boc-amino)-4,5-isopropylidenedioxy-2-pentenoate (Mixture of E-and Z-9).
To a solution of 8a (65 mg, 0.188 mmol) in dry THF (4 mL) was added 3.0 molar equivalents of LiHMDS (0.564 mmol) at ¹10°C under N 2 and the solution was stirred for 5 min at that temperature. The reaction was quenched with 1 M AcOH in THF and the solvent was removed in vacuo to give a residue, which was partitioned between EtOAc and water. The EtOAc solution was washed with brine, dried over MgSO 4 , and evaporated in vacuo to afford a residue, which was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 3/1, v/v). The desired product 9 was obtained as a mixture of E and Z isomers in a ratio of 78:22 in 70% yield (40 mg). IR (neat): 3417, 3340, 2983, 2935, 2875, 1725, 1653, 1512, 1456, 1439, 1369, 1345, 1246, 1158, 1058, 1021, 845, (4S)-2-(N-Boc-amino)-5-hydroxymethylbutenolide (10) . A solution of compound 9 (E/Z = 78/22, 160 mg, 0.53 mmol) and 1 M HCl in MeOH (2.0 mL) was stirred for 1 d under air. After neutralization with NaHCO 3 solution at 0°C, the solvent was removed in vacuo to give a residue, which was partitioned between EtOAc and water. The organic solution was washed with brine, dried over MgSO 4 , and concentrated under reduced pressure. The residue was purified with preparative TLC (SiO 2 , hexane/ EtOAc = 1/1, v/v) to afford the product 10 in 61% yield (74 mg). Mp 123.0124.0°C (EtOAchexane); ½¡ 25 D +18.14°(c 0.19, CHCl 3 ); IR (KBr): 3425, 2979, 1767, 1662, 1538, 1456, 1370, 1344, 1315, 1241, 1160, 1075, 1045, 1016, 934, 888, 849 (4S)-2-(N-Boc-amino)-5-(t-butyldiphenylsiloxy)methylbutenolide (11). A solution of 10 (85 mg, 0.37 mmol), TBDPS-Cl (123 mg, 0.45 mmol), and imidazole (76 mg, 1.12 mmol) in DMF (3 mL) was allowed to stir for 4 h at room temperature. The reaction solution was diluted with water and extracted with ether. The ethereal solution was washed with brine, dried over MgSO 4 , and evaporated in vacuo to give a residue which was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 3/1, v/v). The desired product 11 was obtained as oil in 80% yield (132 mg). ½¡
D
+25.84°(c 1.18, EtOH); IR (neat): 3421, 3317, 3134, 3071, 3049, 2959, 2931, 2893, 2858, 2741, 2344, 1961, 1768, 1734, 1667, 1589, 1519, 1472, 1428, 1392, 1369, 1344, 1316, 1237, 1158, 1115, 1085, 1045, 1010, 937, 904, 857, 823, 772, 742, (3S,5S)-3-(N-Boc-amino)-5-(t-butyldiphenylsiloxy)methyl-£-lactone (12) .
Compound 11 (94 mg, 0.21 mmol) was hydrogenated over 20% palladium hydroxide on carbon (12 mg) in EtOH (3 mL) at room temperature under hydrogen atmosphere for 10 h. Then, the catalyst was filtered through a pad of celite, and the filtrate was removed in vacuo. The residual oil was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 3/1, v/v) to afford compound 12 in 89% yield (88 mg). Oil; ½¡ 25 D +3.56°(c 1.25, EtOH); IR (neat): 3351, 3071, 3050, 2964, 2931, 2894, 2859, 1962, 1894, 1784, 1713, 1589, 1510, 1473, 1456, 1428, 1391, 1367, 1328, 1291, 1254, 1164, 1114, 1051, 1030, 978, 936, 911, 871, 823, 742, A General Procedure for Coupling Reaction of Boc-Amino Acid with cis-4,5-Oxazolidinone Derivatives (13a13k¤). A solution of 3-Boc-4-(methoxycarbonyl)-5-phenyl-cis-4,5-oxazolidin-2-one (2i) (321 mg, 1.0 mmol) in 99% formic acid (20 mL) was allowed to stand for 40 min. Evaporation of the solvent afforded the N-deprotected oxazolidinone derivative in quantitative yield (mp 147148°C from EtOAchexane). To the resulting oxazolidinone (221 mg, 1.0 mmol) in dry THF (5 mL) was added dropwise 1.1 molar equivalents of LDA at ¹78°C under N 2 . After 5 min a solution of Boc-Ala-ONSu (429 mg, 1.1 mmol) in THF (5 mL) was added at ¹78°C followed by the addition of a solution of DMAP (12 mg, 0.1 mmol) in dry THF (2 mL). The solution was then warmed to ¹10°C and kept at that temperature for 3 h. After quenching the reaction with 1 M AcOH in THF at ¹78°C, the solvent was removed in vacuo to give a residue, which was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc. The combined EtOAc extracts were washed with a solution of 10% NaHCO 3 and brine, dried over MgSO 4 , and concentrated under reduced pressure. The residue was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 2/1, v/v) to give 13i as major product and 13i¤ as minor one in 51% (199 mg) and 45% (177 mg) yields, respectively. 13i: mp 160.0161.0°C (EtOAc hexane); ½¡ 25 D ¹54.03°(c 0.74, EtOH); IR (KBr): 3423, 2985, 2953, 1806, 1748, 1722, 1702, 1503, 1368, 1340, 1243, 1216, 1196, 1143, 1020, 757, 701 3374, 2981, 2934, 1784, 1747, 1725, 1692, 1627, 1521, 1359, 1249, 1215, 1200, 1166, 1140, 1012, 760, The physical and spectral data of compounds 13a13h¤ and 13j13k¤ are shown in the following.
3-(Boc-glycyl)-cis-4-methoxycarbonyl-5-methyloxazolidin-2-one (13a): Oil; IR (film): 3355, 2979, 2925, 2852, 1749, 1521, 1393, 1368, 1218, 1164, 1099, 1054, 952, 862, 3391, 2980, 2936, 1794, 1754, 1707, 1507, 1454, 1392, 1367, 1217, 1166, 1099, 1071, 1054, 1020, 981, 953, 862 3389, 2980, 2936, 1793, 1755, 1706, 1505, 1454, 1390, 1367, 1217, 1166, 1099, 1071, 1054, 1020, 953, 862, 758 3440, 3004, 2973, 2870, 2840, 1795, 1760, 1718, 1698, 1509, 1458, 1366, 1212, 1164, 1100, 882, 795 3437, 3392, 2972, 2935, 2875, 1793, 1750, 1705, 1500, 1392, 1365, 1211, 1164, 1098, 1054, 1017, 758, 667 1.44 (s, 9H), 2.202.24 (br, 1H), 3.79 (s, 3H), 4.77 (d, J = 8.44 Hz, 1H), 4.86 (dq, J = 6.42, 8.44 Hz, 1H), 5.115.25 (br, 1H), 5.36 (dd, J = 3.67, 9.35 Hz, 1H 3396, 3331, 2963, 2937, 2873, 1796, 1746, 1712, 1524, 1390, 1367, 1253, 1212, 1167, 1100, 1051, 1026, 951, 786, 759 : 3352, 2960, 2872, 1793, 1756, 1708, 1507, 1456, 1439, 1366, 1212, 1168, 1098, 1051, 1024, 757, 666 cm ¹1 ; 1 H NMR (300 MHz, CDCl 3 ): ¤ 0.93 (d, J = 6.60 Hz, 3H), 1.03 (d, J = 6.24 Hz, 3H), 1.421.48 (m, 12H), 1.701.88 (m, 3H), 3.80 (s, 3H), 4.77 (d, J = 8.44 Hz, 1H), 4.86 (dq, J = 6.42, 8.44 Hz, 1H), 5.09 (d, J = 8.49 Hz, 1H), 5.385.56 (m, 1H 3356, 3062, 3006, 2979, 2933, 1715, 1516, 1438, 1393, 1368, 1215, 1166, 1054, 1030, 754, 701, 667 3626, 3393, 3026, 3006, 2979, 2935, 1825, 1793, 1753, 1709, 1497, 1455, 1369, 1215, 1167, 1073, 1055, 1021, 757 3384, 2979, 2955, 2933, 1793, 1752, 1712, 1496, 1454, 1368, 1211, 1168, 1071, 1022, 756 3340, 2968, 2931, 1793, 1753, 1706, 1497, 1456, 1391, 1368, 1211, 1165, 1143, 1016, 756, : 3442, 3395, 3026, 2970, 2932, 2874, 1793, 1753, 1704, 1497, 1391, 1368, 1215, 1164, 1018, 756, 3-(Boc-glycyl)-cis-4-methoxycarbonyl-5-phenyloxazolidin-2-one (13h): Mp 118.0119.0°C (EtOAchexane); IR (KBr): 3397, 3025, 3008, 2978, 2955, 1794, 1742, 1732, 1697, 1523, 1394, 1381, 1338, 1270, 1249, 1233, 1195, 1168, 1143, 1051, 1018, 941, 795, 701 4.48 (dd, J = 4.40, 19.26 Hz, 1H), 4.71 (dd, J = 6.79, 19.26 Hz, 1H), 5.09 (d, J = 8.99 Hz, 1H), 5.045.12 (br, 1H), 5.82 (d, J = 8.99 Hz, 1H), 7.287.46 (m, 5H : 3416, 2968, 1796, 1748, 1710, 1510, 1456, 1370, 1343, 1217, 1163, 1134, 1053, 1020, 1001, 874, 839, 756, 697 3405, 2970, 2934, 1784, 1749, 1699, 1512, 1357, 1277, 1246, 1217, 1200, 1166, 1140, 1055, 1017, 891, 758, 722 3350, 2960, 2872, 1793, 1756, 1708, 1507, 1456, 1439, 1366, 1212, 1168, 1098, 1051, 1025, A General Procedure for Conversion of Compounds 13a 13k¤ to the Corresponding Dehydropeptides 14a14k¤. To a solution of 13i (70 mg, 0.18 mmol) in dry THF (3 mL) was added 4.0 molar equivalents of LiHMDS in dry THF (2 mL) at ¹45°C under N 2 and the solution was stirred for 50 min at that temperature. After the reaction was quenched with 1 M AcOH in THF at ¹45°C, the solvent was removed in vacuo to give a residue, which was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc and the combined extracts were washed with brine, dried oner MgSO 4 , and concentrated in vacuo. The residual oil was subjected to preparative TLC (SiO 2 , benzene/EtOAc = 4/1, v/v) to give methyl (E)-N-Boc-alanyldehydrophenylalaninate (14i) in 68% (43 mg) and methyl (Z)-N-Boc-alanyldehydrophenylalaninate (14i¤) in 10% (6 mg) yields, respectively. (E)-14i: oil; ½¡ 25 D ¹2.10°(c 0.54, EtOH); IR (film): 3317, 3057, 2979, 2932, 2853, 1718, 1680, 1644, 1493, 1367, 1267, 1167, 1114, 1068, 1020, 858, 769, 737, 3390, 3370, 3058, 2984, 2949, 1715, 1693, 1644, 1500, 1478, 1273, 1206, 1163, 1118, 1065, 1010, 771, In a similar way, compounds 13a13h¤ and 13j13k¤ were converted into 14a14h¤ and 14j14k¤, whose physical and spectral data were shown in following.
Methyl 2-(Boc-glycylamino)-2-butenoate (14a and 14a¤): (E)-14a: oil; IR (film): 3346, 2979, 2933, 1707, 1518, 1393, 1368, 1252, 1167, 1054, 1031, 950, 861, 2982, 2955, 2935, 1738, 1677, 1662, 1531, 1367, 1345, 1254, 1167, 1116, 1070, 1043, 1026, 858, 788, 757, 715 3330, 3276, 3022, 2976, 2955, 2871, 1735, 1685, 1666, 1523, 1434, 1369, 1353, 1248, 1172, 1045, 1021, 1000, 930, 880, 830, 808 3326, 3284, 2955, 2871, 1732, 1685, 1660, 1525, 1508, 1300, 1278, 1247, 1169, 1070, 1045, 932, 876, 806 3281, 3052, 2976, 2925, 2872, 1727, 1664, 1536, 1366, 1352, 1292, 1257, 1166, 1047, 1023, 850, 3348, 2979, 2932, 2853, 1710, 1521, 1454, 1393, 1368, 1280, 1252, 1167, 1054, 950, 861 Methyl 2-(Boc-glycylamino)-5-phenyl-2-pentenoate (14e and 14e¤): (E)-14e: oil; IR (film): 3326, 2978, 2928, 2849, 1715, 1681, 1520, 1455, 1367, 1249, 1165, 1066, 751, 3299, 2979, 2931, 1790, 1684, 1650, 1498, 1366, 1269, 1249, 1164, 1065, 1023, 746 4-(N-Z-amino)-1-butyl Acetate (15) . To a mixture of 4-amino-1-butanol (1.782 g, 20 mmol ) and sodium carbonate (2.332 g, 22 mmol) in water (46 mL) was added dropwise a solution of Z-Cl (3.410 g, 20 mmol) in THF (40 mL) at 0°C. The mixture was allowed to stand overnight at room temperature and the THF was removed in vauo to give a residue, which was partitioned between EtOAc and water. The EtOAc solution was washed with brine, dried, and evaporated in vacuo to afford the product in quantitative yield (4.46 g).
To a solution of the resulting alcohol (4.46 g, 20 mmol) in THF (20 mL) was added a catalytic amount of DMAP followed by the addition of acetic anhydride (3.77 mL, 40 mmol) at room temperature. After stirring for 20 min, the reaction was quenched with a saturated solution of aqueous NaHCO 3 and the solvent was removed in vacuo. The residue was dissolved in EtOAc and the organic solution was washed with brine, dried over MgSO 4 , and evaporated under reduced pressure to afford the desired product 15 in 94% yield (4.98 g). Oil; IR (neat): 3344, 3033, 2951, 1723, 1603, 1530, 1455, 1366, 1247, 1138, 1038, 993, 741, 4-(N-Boc-N-Z-amino)-1-butyl Acetate (16) . To a solution of 15 (4.98 g, 18.7 mmol) in dry THF (15 mL) was added a solution of a catalytic amount of DMAP in dry THF (5 mL) at 0°C followed by the addition of a solution of Boc 2 O (6.22 g, 28.5 mmol) in dry THF at that temperature. The solution was allowed to stand overnight at room temperature. After evaporation of the solvent, the residue was partitioned between EtOAc and water. The organic solution was washed with brine, dried over MgSO 4 , and concentrated under reduced pressure to give compound 16 in 81% yield (5.58 g). Oil; IR (neat): 2978, 1792, 1739, 1697, 1609, 1587, 1550, 1498, 1475, 1369, 1290, 1240, 1202, 1100, 1072, 852, 780, 753, 4-(N-Boc-N-Z-amino)-1-butanol (17) . Compound 16 (1.120 g, 3.07 mmol) was dissolved in 0.5 M HCl in MeOH (63 mL) at 0°C. The solution was gradually warmed to room temperature and allowed to stand overnight. After neutralization with a saturatated solution of NaHCO 3 at 0°C, the MeOH was removed in vacuo to afford a residue, which was extracted with EtOAc. The EtOAc solution was washed with brine, dried over MgSO 4 , and evaporated in vacuo to give a residue, which was subjected to silica gel column chromatography (eluent; hexane/ EtOAc = 1/1, v/v) giving the product 17 (765 mg, 77%). Oil; IR (neat): 3487, 2977, 2938, 2870, 1782, 1736, 1455, 1369, 1294, 1253, 1119, 1065, 1030, Isomerization of the (E)-N-Boc-¡,¢-didehydroamino Acid Methyl Ester 1 to the Corresponding Z Isomer 1¤ by Iodine. To a solution of 1a (41 mg, 0.19 mmol) in dry THF (2 mL) was added a catalytic amount of iodine at room temperature under N 2 . The solution was stirred for 19 h at that temperature and quenched with a saturated solution of NaHSO 3 . The solvent was removed in vacuo to afford the residue, which was extracted with EtOAc. The organic solution was washed with brine, dried over MgSO 4 , and concentrated in vacuo to give a residue, which was subjected to preparative TLC (SiO 2 , hexane/EtOAc = 4/1, v/v) to afford Z isomer, 1a¤ (35 mg) and E isomer, 1a (<2 mg).
Compounds 1b1h were isomerized to their Z isomers in the same way. The results are summarized in Table 7 .
